Patent: 8,461,120

✉ Email this page to a colleague

Summary for Patent: 8,461,120

Title:	Macrocyclic compounds pounds and methods of use thereof
Abstract:	The invention features novel macrocyclic compounds, methods of making the compounds, pharmaceutical compositions including the compounds, and methods of treatment using the compounds.
Inventor(s):	Hans-Jurgen Gutke, Michael Burnet, Jan-Hinrich Guse
Assignee:	Synovo GmbH
Application Number:	US12/847,740
Patent Claims:	see list of patent claims

Details for Patent 8,461,120

Glossary

Subscribe to access the full database, or Get Started Free
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Sanofi-aventis U.s. Llc	ADMELOG	insulin lispro	Injection	209196	December 11, 2017	8,461,120	2030-07-30
Sanofi-aventis U.s. Llc	ADMELOG	insulin lispro	Injection	209196	October 19, 2018	8,461,120	2030-07-30
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

International Patent Family for US Patent 8,461,120

Subscribe to access the full database, or Get Started Free
Country	Patent Number	Estimated Expiration
United States of America	7767797	⤷ Get Started Free
United States of America	2011028417	⤷ Get Started Free
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.